Eric Dudl

1.4k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Eric Dudl is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Eric Dudl has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Hematology and 2 papers in Oncology. Recurrent topics in Eric Dudl's work include Hematopoietic Stem Cell Transplantation (4 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). Eric Dudl is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). Eric Dudl collaborates with scholars based in United States. Eric Dudl's co-authors include Kenneth I. Weinberg, Richard M. Murray, Charles D. Surh, Joyce T. Tan, Eric M. Leroy, Jonathan Sprent, Sohvi Hörkkö, Silvia S. Pierangeli, D. Ware Branch and Robert Terkeltaub and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Eric Dudl

8 papers receiving 1.1k citations

Hit Papers

IL-7 is critical for homeostatic proliferation and surviv... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Dudl United States 6 917 179 159 147 146 8 1.2k
Lino L. Teichmann Germany 10 675 0.7× 230 1.3× 199 1.3× 216 1.5× 185 1.3× 26 1.2k
Josef Birkmann Germany 22 454 0.5× 569 3.2× 36 0.2× 150 1.0× 147 1.0× 53 1.3k
Eva J.A. van Wanrooij Netherlands 13 579 0.6× 146 0.8× 114 0.7× 304 2.1× 24 0.2× 14 881
Hélène Jouault France 16 191 0.2× 97 0.5× 73 0.5× 240 1.6× 369 2.5× 33 801
Shigetoshi Ohga Japan 7 377 0.4× 108 0.6× 34 0.2× 363 2.5× 142 1.0× 11 735
Masato Yagita Japan 17 618 0.7× 290 1.6× 99 0.6× 243 1.7× 188 1.3× 52 1.1k
G Steiger Switzerland 17 476 0.5× 30 0.2× 154 1.0× 142 1.0× 255 1.7× 27 804
Rie Tabata Japan 16 284 0.3× 180 1.0× 42 0.3× 187 1.3× 148 1.0× 48 937
Ana I. Romero Sweden 15 423 0.5× 166 0.9× 140 0.9× 213 1.4× 74 0.5× 25 1.1k
Francisco Vidal Spain 19 179 0.2× 68 0.4× 34 0.2× 440 3.0× 287 2.0× 60 985

Countries citing papers authored by Eric Dudl

Since Specialization
Citations

This map shows the geographic impact of Eric Dudl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Dudl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Dudl more than expected).

Fields of papers citing papers by Eric Dudl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Dudl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Dudl. The network helps show where Eric Dudl may publish in the future.

Co-authorship network of co-authors of Eric Dudl

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Dudl. A scholar is included among the top collaborators of Eric Dudl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Dudl. Eric Dudl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chung, Brile, Dullei Min, Mark R. Krampf, et al.. (2010). Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 17(1). 48–60. 15 indexed citations
2.
Shi, Ranxin, Daniel Ré, Eric Dudl, et al.. (2010). Chemical Biology Strategy Reveals Pathway-Selective Inhibitor of NF-κB Activation Induced by Protein Kinase C. ACS Chemical Biology. 5(3). 287–299. 14 indexed citations
3.
Chung, Brile, Eric Dudl, Akira Toyama, Lora W. Barsky, & Kenneth I. Weinberg. (2007). Importance of Interleukin-7 in the Development of Experimental Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 14(1). 16–27. 29 indexed citations
4.
Chung, Brile, et al.. (2007). Prevention of graft-versus-host disease by anti–IL-7Rα antibody. Blood. 110(8). 2803–2810. 30 indexed citations
5.
Chung, Brile, Eric Dudl, Akira Toyama, et al.. (2004). IL-7 is necessary for the development of experimental graft-versus-host disease (GVHD). Biology of Blood and Marrow Transplantation. 10. 52–52. 3 indexed citations
6.
Senadheera, Shantha, Amee J. George, Lora W. Barsky, et al.. (2004). Transcriptional Response to IL-7 by Immature Human Thymocytes Demonstrates Specific Effects on Differentiation as Well as Survival Maintenance and Proliferation.. Blood. 104(11). 114–114. 3 indexed citations
7.
Tan, Joyce T., Eric Dudl, Eric M. Leroy, et al.. (2001). IL-7 is critical for homeostatic proliferation and survival of naïve T cells. Proceedings of the National Academy of Sciences. 98(15). 8732–8737. 788 indexed citations breakdown →
8.
Hörkkö, Sohvi, Elizabeth R. Miller, Eric Dudl, et al.. (1996). Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.. Journal of Clinical Investigation. 98(3). 815–825. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026